Skip to main content
SpringerLink
Log in

Neonatal Hemochromatosis and Gestational Alloimmune Liver Disease

  • Chapter
  • First Online:
Diseases of the Liver in Children

Abstract

Neonatal hemochromatosis (NH) is defined as severe neonatal liver disease in association with siderosis of extrahepatic tissues. It is the phenotypic consequence of severe fetal liver disease. Gestational Alloimmune Liver Disease (GALD) is the cause of fetal liver injury leading to nearly all cases of NH. The mechanism of GALD involves maternal IgG alloantibodies directed against a fetal hepatocyte antigen. Fetal complement is bound and the terminal complement cascade is activated, resulting in formation of membrane attack complex and hepatocyte injury and death. In addition to causing chronic liver injury and the NH phenotype, GALD can also cause acute liver failure in the fetus and newborn, often in the absence siderosis. Identification of GALD as the common cause of NH has led to better mechanistic understanding of NH and to a more focused diagnostic approach. Addressing the immune mechanism has led to improved treatment of affected newborns. Treatment during gestation is effective in preventing recurrent GALD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Knisely AS, Mieli-Vergani G, Whitington PF. Neonatal hemochromatosis. Gastroenterol Clin North Am. 2003;32:877–89, vi–vii.

    Article  PubMed  CAS  Google Scholar 

  2. Whitington PF. Fetal and infantile hemochromatosis. Hepatology. 2006;43:654–60.

    Article  PubMed  CAS  Google Scholar 

  3. Cottier H. A hemochromatosis similar disease in newborn. Schweiz Med Wochenschr. 1957;87:39–43.

    PubMed  CAS  Google Scholar 

  4. Laurendeau T, Hill JE, Manning GB. Idiopathic neonatal hemochromatosis in siblings. An inborn error of metabolism. Arch Pathol. 1961;72:410–23.

    PubMed  CAS  Google Scholar 

  5. Bonilla S, Prozialeck JD, Malladi P, Pan X, Yu S, Melin-Aldana H, Whitington PF. Neonatal iron overload and tissue siderosis due to gestational alloimmune liver disease. J Hepatol. 2012;56:1351–5.

    Article  PubMed  CAS  Google Scholar 

  6. Zoller H, Knisely AS. Control of iron metabolism – lessons from neonatal hemochromatosis. J Hepatol. 2012;56:1226–9.

    Article  PubMed  Google Scholar 

  7. Whitington PF. Gestational alloimmune liver disease and neonatal hemochromatosis. Semin Liver Dis. 2012;32:325–32.

    PubMed  CAS  Google Scholar 

  8. Thaler MM. Fatal neonatal cirrhosis: entity or end result? A comparative study of 24 cases. Pediatrics. 1964;33:721–34.

    PubMed  CAS  Google Scholar 

  9. Witzleben CL, Uri A. Perinatal hemochromatosis: entity or end result? Hum Pathol. 1989;20:335–40.

    Article  PubMed  CAS  Google Scholar 

  10. Hoogstraten J, de Sa DJ, Knisely AS. Fetal liver disease may precede extrahepatic siderosis in neonatal hemochromatosis. Gastroenterology. 1990;98:1699–701.

    PubMed  CAS  Google Scholar 

  11. Whitington PF, Malladi P. Neonatal hemochromatosis: is it an alloimmune disease? J Pediatr Gastroenterol Nutr. 2005;40:544–9.

    Article  PubMed  Google Scholar 

  12. Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics. 2008;121:e1615–21.

    Article  PubMed  Google Scholar 

  13. Whitington PF. Neonatal hemochromatosis: a congenital alloimmune hepatitis. Semin Liver Dis. 2007;27:243–50.

    Article  PubMed  CAS  Google Scholar 

  14. Pan X, Kelly S, Melin-Aldana H, Malladi P, Whitington PF. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. Hepatology. 2010;51:2061–8.

    Article  PubMed  Google Scholar 

  15. Hoftman AC, Hernandez MI, Lee KW, Stiehm ER. Newborn illnesses caused by transplacental antibodies. Adv Pediatr. 2008;55:271–304.

    Article  PubMed  Google Scholar 

  16. Ruchelli ED, Uri A, Dimmick JE, Bove KE, Huff DS, Duncan LM, Jennings JB, et al. Severe perinatal liver disease and Down syndrome: an apparent relationship. Hum Pathol. 1991;22:1274–80.

    Article  PubMed  CAS  Google Scholar 

  17. Cheung PC, Ng WF, Chan AK. Neonatal haemochromatosis associated with Down syndrome. J Paediatr Child Health. 1995;31:249–52.

    Article  PubMed  CAS  Google Scholar 

  18. Neil E, Cortez J, Joshi A, Bawle EV, Poulik J, Zilberman M, El-Baba MF, et al. Hepatic failure, neonatal hemochromatosis and porto-pulmonary hypertension in a newborn with trisomy 21 – a case report. Ital J Pediatr. 2010;36:38.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hanchard NA, Shchelochkov OA, Roy A, Wiszniewska J, Wang J, Popek EJ, Karpen S, et al. Deoxyguanosine kinase deficiency presenting as neonatal hemochromatosis. Mol Genet Metab. 2011;103:262–7.

    Article  PubMed  CAS  Google Scholar 

  20. Nobre S, Grazina M, Silva F, Pinto C, Goncalves I, Diogo L. Neonatal liver failure due to deoxyguanosine kinase deficiency. BMJ Case Rep. 2012;2012.

    Google Scholar 

  21. Pronicka E, Weglewska-Jurkiewicz A, Taybert J, Pronicki M, Szymanska-Debinska T, Karkucinska-Wieckowska A, Jakobkiewicz-Banecka J, et al. Post mortem identification of deoxyguanosine kinase (DGUOK) gene mutations combined with impaired glucose homeostasis and iron overload features in four infants with severe progressive liver failure. J Appl Genet. 2011;52:61–6.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  22. Shneider BL, Setchell KD, Whitington PF, Neilson KA, Suchy FJ. Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis. J Pediatr. 1994;124:234–8.

    Article  PubMed  CAS  Google Scholar 

  23. Siafakas CG, Jonas MM, Perez-Atayde AR. Abnormal bile acid metabolism and neonatal hemochromatosis: a subset with poor prognosis. J Pediatr Gastroenterol Nutr. 1997;25:321–6.

    Article  PubMed  CAS  Google Scholar 

  24. Ueki I, Kimura A, Chen HL, Yorifuji T, Mori J, Itoh S, Maruyama K, et al. SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta4-steroid 5beta-reductase deficiency. J Gastroenterol Hepatol. 2009;24:776–85.

    Article  PubMed  CAS  Google Scholar 

  25. Silver MM, Beverley DW, Valberg LS, Cutz E, Phillips MJ, Shaheed WA. Perinatal hemochromatosis. Clinical, morphologic, and quantitative iron studies. Am J Pathol. 1987;128:538–54.

    PubMed  CAS  PubMed Central  Google Scholar 

  26. Knisely AS. Neonatal hemochromatosis. Am J Gastroenterol. 1988;83:1312–3.

    PubMed  CAS  Google Scholar 

  27. Witzleben CL, Uri AK. Neonatal hemochromatosis. Am J Gastroenterol. 1988;83:1429.

    PubMed  CAS  Google Scholar 

  28. Knisely AS. Neonatal hemochromatosis. Adv Pediatr. 1992;39:383–403.

    PubMed  CAS  Google Scholar 

  29. Silver MM, Valberg LS, Cutz E, Lines LD, Phillips MJ. Hepatic morphology and iron quantitation in perinatal hemochromatosis. Comparison with a large perinatal control population, including cases with chronic liver disease. Am J Pathol. 1993;143:1312–25.

    PubMed  CAS  PubMed Central  Google Scholar 

  30. Bonilla SF, Melin-Aldana H, Whitington PF. Relationship of proximal renal tubular dysgenesis and fetal liver injury in neonatal hemochromatosis. Pediatr Res. 2010;67:188–93.

    Article  PubMed  CAS  Google Scholar 

  31. Debray FG, de Halleux V, Guidi O, Detrembleur N, Gaillez S, Rausin L, Goyens P, et al. Neonatal liver cirrhosis without iron overload caused by gestational alloimmune liver disease. Pediatrics. 2012;129:e1076–9.

    Article  PubMed  Google Scholar 

  32. Knisely AS. Iron and pediatric liver disease. Semin Liver Dis. 1994;14:229–35.

    Article  PubMed  CAS  Google Scholar 

  33. Whitington PF, Pan X, Kelly S, Melin-Aldana H, Malladi P. Gestational alloimmune liver disease in cases of fetal death. J Pediatr. 2011;159:612–6.

    Article  PubMed  Google Scholar 

  34. Bale PM, Kan AE, Dorney SF. Renal proximal tubular dysgenesis associated with severe neonatal hemosiderotic liver disease. Pediatr Pathol. 1994;14:479–89.

    Article  PubMed  CAS  Google Scholar 

  35. Johal JS, Thorp JW, Oyer CE. Neonatal hemochromatosis, renal tubular dysgenesis, and hypocalvaria in a neonate. Pediatr Dev Pathol. 1998;1:433–7.

    Article  PubMed  CAS  Google Scholar 

  36. Morris S, Akima S, Dahlstrom JE, Ellwood D, Kent A, Falk MC. Renal tubular dysgenesis and neonatal hemochromatosis without pulmonary hypoplasia. Pediatr Nephrol. 2004;19:341–4.

    Article  PubMed  Google Scholar 

  37. Waters PJ, Khashu M, Lillquist Y, Senger C, Mattman A, Demos M, Setchell K, et al. Neonatal hyperphenylalaninemia, perinatal hemochromatosis, and renal tubulopathy: a unique patient or a novel metabolic disorder? Mol Genet Metab. 2005;86 Suppl 1:S148–52.

    Article  PubMed  CAS  Google Scholar 

  38. Shneider BL. Neonatal liver failure. Curr Opin Pediatr. 1996;8:495–501.

    Article  PubMed  CAS  Google Scholar 

  39. Durand P, Debray D, Mandel R, Baujard C, Branchereau S, Gauthier F, Jacquemin E, et al. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediatr. 2001;139:871–6.

    Article  PubMed  CAS  Google Scholar 

  40. Squires Jr RH, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, Dhawan A, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652–8.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Sundaram SS, Alonso EM, Whitington PF. Liver transplantation in neonates. Liver Transpl. 2003;9:783–8.

    Article  PubMed  Google Scholar 

  42. Grabhorn E, Richter A, Burdelski M, Rogiers X, Ganschow R. Neonatal hemochromatosis: long-term experience with favorable outcome. Pediatrics. 2006;118:2060–5.

    Article  PubMed  Google Scholar 

  43. Grabhorn E, Richter A, Fischer L, Ganschow R. Emergency liver transplantation in neonates with acute liver failure: long-term follow-up. Transplantation. 2008;86:932–6.

    Article  PubMed  Google Scholar 

  44. Rodrigues F, Kallas M, Nash R, Cheeseman P, D’Antiga L, Rela M, Heaton ND, et al. Neonatal hemochromatosis – medical treatment vs. transplantation: the King’s experience. Liver Transpl. 2005;11:1417–24.

    Article  PubMed  Google Scholar 

  45. Woodle ES, Millis JM, So SK, McDiarmid SV, Busuttil RW, Esquivel CO, Whitington PF, et al. Liver transplantation in the first three months of life. Transplantation. 1998;66:606–9.

    Article  PubMed  CAS  Google Scholar 

  46. Whitington PF, Kelly S, Ekong UD. Neonatal hemochromatosis: fetal liver disease leading to liver failure in the fetus and newborn. Pediatr Transplant. 2005;9:640–5.

    Article  PubMed  Google Scholar 

  47. Ekong UD, Kelly S, Whitington PF. Disparate clinical presentation of neonatal hemochromatosis in twins. Pediatrics. 2005;116:e880–4.

    Article  PubMed  Google Scholar 

  48. Knisely AS, O’Shea PA, Stocks JF, Dimmick JE. Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis. J Pediatr. 1988;113:871–4.

    Article  PubMed  CAS  Google Scholar 

  49. Hayes AM, Jaramillo D, Levy HL, Knisely AS. Neonatal hemochromatosis: diagnosis with MR imaging. AJR Am J Roentgenol. 1992;159:623–5.

    Article  PubMed  CAS  Google Scholar 

  50. Udell IW, Barshes NR, Voloyiannis T, Lee TC, Karpen SJ, Carter BA, Finegold M, et al. Neonatal hemochromatosis: radiographical and histological signs. Liver Transpl. 2005;11:998–1000.

    Article  PubMed  Google Scholar 

  51. Flynn DM, Mohan N, McKiernan P, Beath S, Buckels J, Mayer D, Kelly DA. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed. 2003;88:F124–7.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  52. Vohra P, Haller C, Emre S, Magid M, Holzman I, Ye MQ, Iofel E, et al. Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediatr. 2000;136:537–41.

    Article  PubMed  CAS  Google Scholar 

  53. Rand EB, Karpen SJ, Kelly S, Mack CL, Malatack JJ, Sokol RJ, Whitington PF. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr. 2009;155:566–71.

    Article  PubMed  CAS  Google Scholar 

  54. Leonis MA, Balistreri WF. Neonatal hemochromatosis: it’s OK to say “NO” to antioxidant-chelator therapy. Liver Transpl. 2005;11:1323–5.

    Article  PubMed  Google Scholar 

  55. Ekong UD, Melin-Aldana H, Whitington PF. Regression of severe fibrotic liver disease in 2 children with neonatal hemochromatosis. J Pediatr Gastroenterol Nutr. 2008;46:329–33.

    Article  PubMed  Google Scholar 

  56. Whitington PF, Hibbard JU. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet. 2004;364:1690–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Organ Transplantation, Siragusa Transplantation Center, Ann and Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, USA

    Peter F. Whitington MD

  2. Department of Pediatrics, Northwestern University Feinberg School of Medicine, 225 East Chicago Avenue, 57, Chicago, IL, 60611-2605, USA

    Peter F. Whitington MD

Authors
  1. Peter F. Whitington MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter F. Whitington MD .

Editor information

Editors and Affiliations

  1. University of Washington School of Medicine, Seattle Children’s Hospital, Seattle, Washington, USA

    Karen F. Murray

  2. University of Washington School of Medicine, Seattle Children’s Hospital, Seattle, Washington, USA

    Simon Horslen

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Whitington, P.F. (2014). Neonatal Hemochromatosis and Gestational Alloimmune Liver Disease. In: Murray, K., Horslen, S. (eds) Diseases of the Liver in Children. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9005-0_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-9005-0_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-9004-3

  • Online ISBN: 978-1-4614-9005-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation